[go: up one dir, main page]

BR112012016676A2 - promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral. - Google Patents

promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral.

Info

Publication number
BR112012016676A2
BR112012016676A2 BR112012016676-0A BR112012016676A BR112012016676A2 BR 112012016676 A2 BR112012016676 A2 BR 112012016676A2 BR 112012016676 A BR112012016676 A BR 112012016676A BR 112012016676 A2 BR112012016676 A2 BR 112012016676A2
Authority
BR
Brazil
Prior art keywords
oral application
promoter
dna damage
elastase activity
damage repair
Prior art date
Application number
BR112012016676-0A
Other languages
English (en)
Japanese (ja)
Inventor
Sugimoto Saho
Sone Toshiro
Chiba Katsuyoshi
Original Assignee
Kabushiki Kaisha Yakult Honsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabushiki Kaisha Yakult Honsa filed Critical Kabushiki Kaisha Yakult Honsa
Publication of BR112012016676A2 publication Critical patent/BR112012016676A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral. a presente invenção fornece um promotor de reparo do dano ao dna para a aplicação oral e um supressor da atividade de elastase para a aplicação oral. a invenção fornece um promotor de reparo do dano ao dna e um supressor da atividade de elastase para a aplicação oral contendo, como um ingrediente ativo, uma bactéria pertencente ao gênero bifidobacterium.
BR112012016676-0A 2010-01-06 2010-12-28 promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral. BR112012016676A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2010001576 2010-01-06
JP2010001550 2010-01-06
JP2010001550 2010-01-06
JP2010001576 2010-01-06
PCT/JP2010/073796 WO2011083738A1 (ja) 2010-01-06 2010-12-28 経口用のｄｎａ損傷修復促進剤及びエラスターゼ活性抑制剤

Publications (1)

Publication Number Publication Date
BR112012016676A2 true BR112012016676A2 (pt) 2018-06-05

Family

ID=44305474

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012016676-0A BR112012016676A2 (pt) 2010-01-06 2010-12-28 promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral.

Country Status (8)

Country Link
US (1) US20130004463A1 (pt)
EP (1) EP2522355B1 (pt)
JP (1) JP5688376B2 (pt)
KR (1) KR101807328B1 (pt)
BR (1) BR112012016676A2 (pt)
MX (1) MX2012007873A (pt)
TW (1) TWI565471B (pt)
WO (1) WO2011083738A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102002380B1 (ko) 2012-10-10 2019-07-23 삼성전자 주식회사 반도체 장치 및 그 제조 방법
JP6412865B2 (ja) * 2013-03-13 2018-10-24 株式会社ヤクルト本社 ビフィドバクテリウム・ブレーベ株特異的遺伝子
CN109985056A (zh) * 2013-10-30 2019-07-09 可劳迈戴斯有限公司 用于在治疗皮肤病中局部使用的烟酰胺核苷组合物
US9957496B2 (en) 2013-12-04 2018-05-01 Kabushiki Kaisha Yakult Honsha Method for regulating acid resistance of microbes
WO2016080448A1 (ja) * 2014-11-19 2016-05-26 株式会社ヤクルト本社 セリアック病予防治療剤
WO2017063066A1 (en) * 2015-10-15 2017-04-20 Natura Cosméticos S.A. Cosmetic composition having probiotic bacteria
JP7489045B2 (ja) * 2018-09-25 2024-05-23 国立研究開発法人国立循環器病研究センター 抗腫瘍効果増強剤
CN109912698B (zh) * 2018-11-22 2023-10-13 福建御冠食品有限公司 一种提高鱼肠弹性的弹性多肽、鱼肠及其制备方法
WO2022064839A1 (ja) * 2020-09-24 2022-03-31 森永乳業株式会社 コラーゲン、エラスチン若しくはヒアルロン酸の産生又は分解に関与する遺伝子の発現調節用組成物
JP7709860B2 (ja) * 2021-06-23 2025-07-17 高橋 希之 評価装置、評価システム、評価プログラム、及び評価方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
JP2563197B2 (ja) * 1988-04-08 1996-12-11 株式会社ヤクルト本社 ビフィドバクテリウム・ブレーベおよび飲食品
EP1120108B1 (en) * 1998-10-09 2006-08-02 Kabushiki Kaisha Yakult Honsha Skin care preparations for external use
JP2001112437A (ja) * 1999-10-18 2001-04-24 Yakult Honsha Co Ltd ビフィドバクテリウム属細菌含有飲食品の製造方法
WO2002028402A1 (en) * 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
JP4707246B2 (ja) * 2001-02-15 2011-06-22 株式会社ヤクルト本社 消化器障害予防・治療剤
ATE350010T1 (de) * 2001-02-23 2007-01-15 Richter Chem Lab Zusammensetzung zur topischen anwendung
US6873538B2 (en) * 2001-12-20 2005-03-29 Micron Technology, Inc. Programmable conductor random access memory and a method for writing thereto
MXPA04008177A (es) * 2002-02-21 2005-06-08 Nestle Sa Composicion oralmente administrable, para la fotoproteccion de la piel.
PT1490077E (pt) * 2002-02-21 2008-02-28 Oreal Composição fotoprotectora para a pele administrável por via oral
JP4011938B2 (ja) * 2002-03-08 2007-11-21 株式会社ヤクルト本社 脂質代謝改善剤及びそれを含有する食品
JP2006076926A (ja) * 2004-09-09 2006-03-23 Toyo Shinyaku:Kk ピーマンから得られる発酵物
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
JP5254682B2 (ja) * 2008-06-27 2013-08-07 株式会社ヤクルト本社 経口摂取用皮膚性状改善剤
KR101838762B1 (ko) * 2010-02-24 2018-03-14 가부시키가이샤 야쿠르트 혼샤 신규 비피도박테리움속 세균의 작출 방법

Also Published As

Publication number Publication date
TWI565471B (zh) 2017-01-11
EP2522355A4 (en) 2014-06-04
US20130004463A1 (en) 2013-01-03
WO2011083738A1 (ja) 2011-07-14
TW201130496A (en) 2011-09-16
EP2522355B1 (en) 2018-02-21
MX2012007873A (es) 2012-07-25
EP2522355A1 (en) 2012-11-14
JPWO2011083738A1 (ja) 2013-05-13
JP5688376B2 (ja) 2015-03-25
KR20120112510A (ko) 2012-10-11
KR101807328B1 (ko) 2017-12-08

Similar Documents

Publication Publication Date Title
BR112012016676A2 (pt) promotor de reparo do dano ao dna para a aplicação oral e inibidor da atividade de elastase para a aplicação oral.
UA109123C2 (uk) Пробіотична композиція для застосування в лікуванні запалення кишечнику
NI201001032A (es) Formas crsitalinas de dimetoxi docetaxel y metodo para preparar el mismo.
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
UY33937A (es) Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina
MX376284B (es) Una composición que comprende un agente antibiótico y un agente dispersante o un agente antiadhesivo.
MX2013000567A (es) Composiciones farmaceuticas de moduladores de c-met.
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
GT201400090A (es) 2-tiopirimidinonas
PH12013501561A1 (en) Histone deacetylase inhibitors and compositions and methods of use thereof
IN2014DN03298A (pt)
EP2576536A4 (en) HEMATOPOETIC PROSTAGLANDIN D2 SYNTHASE INHIBITORS
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
WO2012104240A3 (de) Kosmetische verwendung
PH12015501099A1 (en) Synbiotic composition and use thereof
PH12015500069A1 (en) Histone deacetylase inhibitors and compositions and methods of use thereof
WO2011123524A3 (en) Macrolide inhibitors of mtor
BR112012019920A2 (pt) derivados de piridazina úteis como agonístas de canabinoide-2.
CO6761388A2 (es) Composiciones pharmaceuticas que comprenden alisporivir
CO6680629A2 (es) Compuestos con actividad antibacteriana contra clsotridium
BR112012021104A2 (pt) compositos de silica antimicrobiana
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
BR112013000930A2 (pt) formulações de 14-epi-análogos de vitamina d e cmc

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements